The estimated Net Worth of Nicholas N. Vahanian is at least $531 Thousand dollars as of 26 July 2012. Nicholas Vahanian owns over 30,395 units of Lumos Pharma Inc stock worth over $530,953 and over the last 13 years Nicholas sold LUMO stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Nicholas Vahanian LUMO stock SEC Form 4 insiders trading
Nicholas has made over 1 trades of the Lumos Pharma Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Nicholas exercised 30,395 units of LUMO stock worth $100,911 on 26 July 2012.
The largest trade Nicholas's ever made was exercising 30,395 units of Lumos Pharma Inc stock on 26 July 2012 worth over $100,911. On average, Nicholas trades about 10,132 units every 0 days since 2011. As of 26 July 2012 Nicholas still owns at least 149,144 units of Lumos Pharma Inc stock.
You can see the complete history of Nicholas Vahanian stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Nicholas Vahanian's mailing address?
Nicholas's mailing address filed with the SEC is C/O NEWLINK GENETICS CORPORATION, 2503 SOUTH LOOP DR., SUITE 5100, AMES, IA, 50010.
Insiders trading at Lumos Pharma Inc
Over the last 13 years, insiders at Lumos Pharma Inc have traded over $6,087,405 worth of Lumos Pharma Inc stock and bought 2,157,996 units worth $15,106,881 . The most active insiders traders include Seed Farm, Inc. Stine, Paul R Edick, and Charles J. Jr. Link. On average, Lumos Pharma Inc executives and independent directors trade stock every 257 days with the average trade being worth of $694,335. The most recent stock trade was executed by James E Deerfield Mgmt Iii,... on 6 January 2021, trading 151,723 units of LUMO stock currently worth $3,425,905.
What does Lumos Pharma Inc do?
lumos pharma is an clinical stage biotechnology company focused on developing therapeutics for rare diseases
What does Lumos Pharma Inc's logo look like?
Complete history of Nicholas Vahanian stock trades at Lumos Pharma Inc
Lumos Pharma Inc executives and stock owners
Lumos Pharma Inc executives and other stock owners filed with the SEC include:
-
Richard J. Hawkins,
CEO & Chairman -
Dr. John C. McKew Ph.D.,
Chief Scientific Officer & Pres -
Carl W. Langren,
Consultant -
Bradley J. Powers J.D.,
Chief Compliance Officer & Gen. Counsel -
Eddie L. Varnado M.B.A.,
VP of Fin. & Corp. Controller -
Eddie L. Varnado,
VP of Fin. & Corp. Controller -
Dr. David B. Karpf B.A., M.D.,
Chief Medical Officer -
Aaron Schuchart B.B.A., CPA, M.B.A.,
Chief Bus. Officer -
Lisa Miller,
Sr. Director of Investor Relations -
Lori D. Lawley CPA,
CFO & Principal Accounting Officer -
Seed Farm, Inc. Stine,
10% owner -
Charles J. Jr. Link,
Chairman of the Board & CEO -
Nicholas N. Vahanian,
Pres, Chief Medical Officer -
Gordon H Jr Link,
Chief Financial Officer -
Paul R Edick,
Director -
Joseph Saluri,
Director -
Ernest Iii Talarico,
Director -
David J. Lundquist,
Director -
Kenneth Lynn,
Exec VP of Bus Development -
Thomas A. Raffin,
Director -
Sarah Alexander,
Director -
William J. Ramsey,
Quality Assurance Officer -
James E Deerfield Mgmt Iii,...,